£73.85

Springer Modulation of Protein Stability in Cancer Therapy

Price data last checked 37 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£74 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 54 days • 54 data points (No recent data available)

Historical
Generating forecast...
£73.85 £70.16 £71.63 £73.11 £74.59 £76.07 £77.54 05 April 2026 18 April 2026 01 May 2026 14 May 2026 28 May 2026

Price Distribution

Price distribution over 54 days • 1 price levels

Days at Price
54 days 0 14 27 41 54 £74 Days at Price

Price Analysis

Most common price: £74 (54 days, 100.0%)

Price range: £74 - £74

Price levels: 1 different prices over 54 days

Description

This comprehensive monograph on the role of protein modulation in cancer therapeutics focuses on targeting molecules that regulate protein stability in a variety of tumors. Topics covered include ubiquitin ligases, deubiquitinating enzymes, and the proteasome. From the Back Cover This book contains chapters written by experts in the field of the ubiquitin proteasome system and cancer.  The authors have summarized current information on ubiquitin ligases and proteasomes as potential targets for cancer therapy. Topics covered in the book include an overview of ubiquitin ligases, deubiquitinating enzymes, and the proteasome.  Specific diseases resulting from deregulated ubiquitin ligases, such as Von-Hippel-Lindau disease and Fanconi anemia are also discussed.  Finally, novel approaches and drugs to target proteins involved in sumoylation, ubiquitination, and degradation are described.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 October 2010
Listed Since
10 December 2010

Barcode

No barcode data available

Similar Products You Might Like

Translation and Its Regulation in Cancer Biology and Medicine
84% match

Translation and Its Regulation in Cancer Biology and Medicine

Springer

£115.43 03 Jun 2026
Translation and Its Regulation in Cancer Biology and Medicine
84% match

Translation and Its Regulation in Cancer Biology and Medicine

Springer

£93.56 05 Jun 2026
Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy
83% match

Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy

Springer

£113.76 09 Jun 2026
Ubiquitin
83% match

Ubiquitin

Springer

£116.73 31 May 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
82% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 31 May 2026
Cell Signaling & Molecular Targets in Cancer
82% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 14 May 2026
Proteases and Their Inhibitors in Cancer Metastasis: 4 (Cancer Metastasis - Biology and Treatment, 4)
82% match

Proteases and Their Inhibitors in Cancer Metastasis: 4 (Cancer Metastasis - Biology and Treatment, 4)

Springer

£108.95 11 May 2026
Pharmaceutical Perspectives of Cancer Therapeutics
82% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 06 Jun 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
82% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 05 Jun 2026
The Rho GTPases in Cancer
82% match

The Rho GTPases in Cancer

Springer

£107.98 03 Jun 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
82% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
The Proteasome in Neurodegeneration
82% match

The Proteasome in Neurodegeneration

Springer

£76.38 29 May 2026
Protein Degradation in Health and Disease: 29 (Progress in Molecular and Subcellular Biology, 29)
82% match

Protein Degradation in Health and Disease: 29 (Progress in Molecular and Subcellular Biology, 29)

Springer

£73.31 31 May 2026
Tumor Cell Metabolism: Pathways, Regulation and Biology
82% match

Tumor Cell Metabolism: Pathways, Regulation and Biology

Springer

£76.38 24 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
81% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.87 24 May 2026
Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach
81% match

Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach

Springer

£74.35 06 Jun 2026
Protein Homeostasis Diseases: Mechanisms and Novel Therapies
81% match

Protein Homeostasis Diseases: Mechanisms and Novel Therapies

Academic Press

£135.65 11 Jun 2026
Autophagy and Cancer (Current Cancer Research)
81% match

Autophagy and Cancer (Current Cancer Research)

Springer

£107.98 28 May 2026
Molecular Targeted Therapy of Lung Cancer
81% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.70 06 Jun 2026
81% match

Structural Biology of Ubiquitination: From Mechanisms to Interventions

Academic Press

£145.99 27 May 2026
Molecular Basis for Therapy of AIDS-Defining Cancers
81% match

Molecular Basis for Therapy of AIDS-Defining Cancers

Springer

£107.98 24 May 2026
Nutraceuticals and Cancer
81% match

Nutraceuticals and Cancer

Springer

£113.76 25 May 2026
Autophagy in tumor and tumor microenvironment
81% match

Autophagy in tumor and tumor microenvironment

Springer

£86.90 05 Jun 2026
Cell Signaling & Molecular Targets in Cancer
81% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 19 May 2026